The American Journal of Psychiatry 2006: Vol 163 Index & Table of Contents

2006·8.3 MB·English

yeWalalerei m e-Ven Gate) amp atelob
Following is the author index for volume 163 of the Journal, which covers all material from January 2006
through December 2006. The Journal no longer prints a subject index. Two-letter abbreviations are used for
months. The complete citation for each article is listed under the name of the first author. Coauthors are
listed alphabetically with a cross-reference to the first author; cross-references containing multiple first au-
thor names separated by semicolons indicate multiple articles by the coauthor. Entries other than Reviews
and Overviews and New Research are given the following designations: Editorial (editorial), Images in Neuro-
science (image, neuro), Introspections (introspections), Treatment in Psychiatry (treatment in psychiatry),
Clinical Case Conference (case conf), Images in Psychiatry (image, psych), Book Forum (bk rev), Letters to the
Editor (letter), Official Actions (off acts), and Supplement (suppl). Corrections are cited with the articles to
which they refer. Readers can also use the Journal's website (ajp.psychiatryonline.org) to search by author, is-
sue, subject, section, or keyword.
A Adler L: bk rev, Berman AL, Alvarez CA, Mascarenas C, American Psychiatric Associ-
Jobes DA, Silverman MM: Timmerman I: Increasing ation: Practice guideline
a Campo J see van Os J Adolescent Suicide: Assess- psychosis in a patient for the treatment of
Aalto S see Hirvonen J ment and Intervention, switched from Clozaril to patients with substance
Aaro LE see Mykletun A Second Edition. Je 1116- generic clozapine (letter). use disorders, second edi-
Abbacchi A see Constantino 1117 Ap 746 tion. Au Suppl 1 (correc-
JN Afifi TO, Cox BJ, Sareen J: Aman MG see McDougle CJ tion, Oc 1843)
Gambling-related prob- American Psychiatric Associ-
Abel KM see Webb RT Amat JA, Bronen RA, Saluja S,
lems are chronic and per- ation: Reports to the mem-
Aboujaoude E see Koran LM Sato N, Zhu H, Gorman
sist for the majority of bership (off acts). Se 1655-
Abraham PF, Shirley ER: New individuals with a lifetime DA, Royal J, Peterson BS: 1663
mnemonic for depressive diagnosis of pathological Increased number of sub- Ames M see Kessler RC
symptoms (letter). Fe 329- gambling (letter). Jy 1297 cortical hyperintensities Amital D, Vishne T, Rubinow
330 Agerbo E see Eaton WW on MRI in children and A, Levine J: Observed
Abramson R: Opiate treat- Aggen SH see Fanous AH adolescenwtisth Tourette's effects of creatine mono-
ment for patients in Ahmari SE see Merrill DB syndrome, obsessive-com- hydrate in a patients with
chronic non-cancer pain Akiskal HS see Kessler RC pulsive disorder, and depression and fibromyal-
(letter). Jy 1299 Alagbe O see Pace TWW atitvtietny tidoinso rddeefri.c itJ e h1y1p0e6r-a c- gia (letter). Oc 1840-1841
Abramson RK see Rabionet R Alda M see Kriiger S 1108 Amlo S see Hoglend P
Adams CE see Leonard S$ Aleardi M see Moore CM Amunts K see Schneider F
Ambery F see Page LA
Adams J see Adler CM Allen A see Hollander E Anckarsater H, Stahlberg O,
Adamson JJ see Faraone SV Allen MH, Hirschfeld RM, Amendoeira MC, Cavalcanti Larson T, Hakansson C,
Addington D see McGlashan Wozniak PJ, Baker JD, MT: Nisae Magalhaes da Jutblad S-B, Niklasson L,
TH Bowden CL: Linear rela- Silveira (1905-1999) Nydén A, Wentz E, Wester-
Addington J see McGlashan tionship of valproate (image, psych). Au 1348 gren S, Cloninger CR, Gill-
TH serum concentration to American Board of Psychia- berg C, Rastam M: The
response and optimal try and Neurology: 2005 impact of ADHD and
Adetunji B see Basil B
serum levels for acute annual report of the Amer- autism spectrum disorders
Adetunji B, Mathews M, Osi- mania. Fe 272-275 ican Board of Psychiatry on temperament, charac-
nowo T, Williams A: Ris- Allison KC see Lundgren JD; and Neurology, Inc. (off ter, and personality devel-
peridone for the core O'Reardon JP acts). Au 1460-1463 opment. Jy 1239-1244
symptom domains of Allison SE, von Wahlde L, American Board of Psychia- Anderson GM see Gorman DA
autism (letter). Mr 551 Shockley T, Gabbard GO: try and Neurology: Report Anderson S see Riccardi P
Adewuya AO: Early postnatal The development of the on the 2005 examinations Andersson G see Carlbring P
mood as a risk factor for self in the era of the Inter- (off acts). Au 1464-1477 Andreasen NC see Paz RD
postnatal depression in net and role-playing fan- American Psychiatric Associ- Andreasen NC: Farewell, thou
Nigerian women. Au 1435- tasy games (case conf). Mr ation: APA council reports child of my right hand (edi-
1437 381-385 (off acts). Fe 337-352 torial). Ja 1-2
Adler CM, Adams J, DelBello Alpert JE see Fava M; McGrath Andres C see Laumonnier F
MP, Holland SK, Schmith- PJ; Nierenberg AA American Psychiatric Associ- Andrews J, Wang L, Csernan-
orst V, Levine A, Jarvis K, Altinbas K see Oral ET ation: Highlights of the sky JG, Gado MH, Barch
Strakowski SM: Evidence Altshuler LL see Leverich GS; 2006 Annual Meeting (off DM: Abnormalities of tha-
of white matter pathology Yaeger D acts). Oc 1849-1857 lamic activation and cogni-
in bipolar disorder adoles- Altshuler LL, Suppes T, Black American Psychiatric Associ- tion in schizophrenia. Mr
cents experiencing their DO, Nolen WA, Leverich G, ation: Practice guideline 463-469
first episode of mania: a Keck PE Jr, Frye MA, Kupka for the psychiatric evalua- Anjum A see White T
diffusion tensor imaging R, McElroy SL, Grunze H, tion of adults, second edi- Ansari MS see Riccardi P
study. Fe 322-324 Kitchen CMR, Post R: tion. Je Suppl 1 (correction, Antonarakis SE see Glaser B
Adler DA, McLaughlin TJ, Lower switch rate in Oc 1843) Antoni MH, Wimberly SR,
Rogers WH, Chang H, depressed patients with American Psychiatric Associ- Lechner SC, Kazi A, Sifre T,
Lapitsky L, Lerner D: Job bipolar II than bipolarI ation: Practice guideline Urcuyo KR, Phillips K,
performance deficits due disorder treated adjunc- for the treatment of Smith RG, Petronis VM,
to depression. Se 1569- tively with second-genera- patients with eating disor- Guellati S, Wells KA,
1576 tion antidepressants. Fe ders, third edition. Jy Supp! Blomberg B, Carver CS:
Adler L see Kessler RC 313-315 1 (correction, Se 1649) Reduction of cancer-spe-
Am | Psychiatry 162:12, December 2005 ajp.psychiatryoniine.org 2215
ANNUAL AUTHOR INDEX
cific thought intrusions Babulas V, Factor-Litvak P, pregnancy as a predictor of Berk M, Dodd S, Malhi GS:
and anxiety symptoms Goetz R, Schaefer CA, psychiatric disorders on Depression and mania in
with a stress management Brown AS: Prenatal expo- the Structured Clinical mixed states (image,
intervention among sure to maternal genital Interview for DSM-IV in psych). Jy 1160
women undergoing treat and reproductive infec- young adult offspring. Je Berthoz S see Godart N
ment for breast cancer. Oc tions and adult schizo- 1061-1065 Berv D see Wagner KD
1791-1797 phrenia. My 927-929 Barry JJ see Stonnington CM Bhagwagar Z, Hinz R, Taylor
Anvar J see Nickel MK Bachler E see Nickel MK Barry S see Kanayama G M, Fancy S, Cowen P,
Aperia A, Greengard P: Backes V see Schneider F Barton BA see Klein DJ Grasby P: Increased 5-
Dopamine receptor Badaracco MA see Freedman Barzman DH, DelBello MP: HT2A receptor binding in
response to NMDA stimu- R Topiramate for co-occur- euthymic, medication-free
lation (image, neuro). Oc Badaracco MA: bk rev, Kandel ring bipolar disorder and patients recovered from
1682 ER: Psychiatry, Psycho- disruptive behavior disor- depression: a positron
Appelbaum PS see Dunn LB inalysis, and the New Biol- ders (letter). Au 1451-1452 emission study with
Appelbaum PS: The Council ogy of Mind. Ja 165-166 Basil B, Mathews M, Adetunji 11C}MDL 100,907. Se
on Psychiatry and Law (off Bai YM, Lin C-C, Chen J-Y, Lin B, Budur K: The CATIE 1580-1587
acts). Fe 346-347 C-Y, Su T-P, Chou P: Associ Study (letter). Mr 555 Bhaumik DK see Gibbons RD
Appelbaum PS: Violence and tion of initial antipsy- Bass NJ see Kalsi G Bhugra D see Torres AR
chotic response to
pm1ue3bn1lt9ia-cl1 3p2do1li iscoyr der(se:d itordiaalt)a. anAdu Bak cwlMeoi zgshaetpe i ngveaa inn. a nOdsJ y lJ1o 2n7g6- te1r9m7 9 BBaauueePrro lsMMkSSy: sDMe ea nNaigeirnegn bethreg aAcAa-; BieHKdeiesrrssmlhaefrne lRdJC- ;sB eeeMc okFoearrre a oDnCRe;M ; SV;
Appleby L see Webb RT demic-industrial complex Spencer TJ
Baker A, Richmond R, Haile
Apter A see Nemets H M, Lewin TJ, Carr VJ, Tay- (letter). De 2193 Biederman J, Petty C, Fried R,
Arango C see Artaloytia JF lor RL, Jansons S, Wilhelm Beardslee WR see Reinherz Fontanella J, Doyle AE,
ArangoV see Parsey R\ K: \ randomized con- HZ Seidman LJ, Faraone SV:
Araya R, Flynn T, Rojas G, yf a smoking Beasley C, Meijer D, Kerwin R, Impact of psychometri-
Fritsch R, Simon G: Cost cessation intervention Cotter D, Everall I, Price J: cally defined deficits of
effectiveness of a primary among people with a psy Author retraction. Au 1454 executive functioning in
care treatment program [or tic disorder. No 1934- Bebbington PE see Torres AR adults with attention defi-
depression in low-income i t< Beckmann C see Winterer G cit hyperactivity disorder.
women in Santiago, Chile Baker DG see Geracioti TD Jr Beekman ATF see Schoevers Oc 1730-1738
Au 1379-1387 Baker JD see Allen MH RA Biggs MM see Fava M;
Arcement J see Parsey RV Baker RW see Perlis RH; Beitchman JH, Baldassarra L, McGrath PJ; Trivedi MH
Arciniegas DB: New-onset Tohen M Mik H, De Luca V, King N, Bilker WB see Schneider F;
bipolar disorder in late life Ralasubramani GK see Trivedi Bender D, Ehtesham S, Siegel SJ
a case of mistaken identity MH Kennedy JL: Serotonin Bimson B see Mathews CA
treatment in psychiatry Baldassarra L see Beitchman transporter polymor- Birnbaum H see Kessler RC
Fe 198-203 JH phisms and persistent, Bjerkeset O see Mykletun A
Ardekani BA see Lim KO Baldwin R see Riccardi P pervasive childhood
Arnold LE see McDougle CJ Balon R: bk rev, Evans DL, Foa aggression. Je 1103-1105 Black DO see Altshuler LL
Arranz B see Reynolds GP EB, Gur RE, Hendin H, Belhadj A see Laumonnier F Blackwell AD see Chamber-
lain SR
Arroyo B see Breen G O'Brien CP, Seligman MEP, Belloni DR see Wishart HA
Arsenault NJ see Woodward Walsh BT, eds: Treating and Belmaker RH see Levine J; Blaine J see Roll JM
SH Preventing Adolescent Nemets H Blair RJR see Monk CS
Artaloytia JF, Arango C, Lahti Mental Health Disorders: Benazzi F: Antidepressant- Blankertz L see Cook JA
A, Sanz J, Pascual A, What We Know and What induced or clinician- Blaser DG: bk rev, Cabeza R,
Cubero P, Prieto D, Palomo We Don't Know. A induced suicidality in Nyberg L, Park D: Cogni-
T: Negative signs and Research Agenda for depression? (letter). Se tive Neuroscience of Aging:
symptoms secondary to Improving the Mental 1644 Linking Cognitive and
antipsychotics: a double- HaeaTlt h of Our Youth. Ap Bender D see Beitchman JH Cerebral Aging. Mr 560-
blind, randomized trial ofa 6 JO3—- 1 04 Bender DS see Gunderson JG 561
single dose of placebo Balon R: bk rev, Roberts LW, Benedek EP: bk rev, Ozonoff Blazer DG: bk rev, Galanter M:
haloperidol, and risperi- Hilty D, eds: Handbook of S, Rogers SJ, Hendren RL, Spirituality and the
done in healthy volunteers Career Development in eds: Autism Spectrum Dis- Healthy Mind: Science,
Mr 488-493 Academic Psychiatry and orders: A Research Review Therapy, and the Need for
Aryal S see Pavuluri MN Behavioral Sciences. Au for Practitioners. Fe 332- Personal Meaning. Je 1115-
Ashley-Koch AE see Rabionet 1455-1456 333 1116
R Balon R: SSRI-associated sex- Benitez J see Fitzgerald PB Bleich S see Hillemacher T
ual dysfunction (treatment
Assalian P see Rosen R in psychiatry). Se 1504- Benjamin L see Seritan AL Bloch S see Kissane DW
Attiullah N see Zimmerman 1509 Benjamin L: Balance beam Block JJ: Ethical concerns
M Bammer R see Cascio C introspections). Je 979- regarding olanzapine ver-
Augustyns I see Reyes M Bangerter K see Rosen R 980 sus placebo in patients
Aulakh JS see Yohanan M Banov MD see Tohen M Benjamin LS: Review of Inter- prodromally symptomatic
Austin KL see Valenstein M Banzato CEM: bk rev, Sadler personal Reconstructive for psychosis (letter). Oc
Therapy (lettez). Ja 161-162 1838
Aydt EE see Skosnik PD JZ: Values and Psychiatric
Bennett T see Gabbard GO Blomberg B see Antoni MH
Diagnosis. My 943-944
Barch DM see Andrews J Berber M see Rosen R Bloom A see Murphy K
B Barkley R see Kessler RC Berg KC see Lundgren JD Blow FC see Valenstein M
Barr HM, Bookstein FL, Berger SR see Reinherz HZ Blumenfield M: Report oft he
Babbar JP: Frontline treat- O'Malley KD, Connor PD, Bergh C see Sédersten P Speaker-Elect (off acts). Se
ment of combat stress Huggins JE, Streissguth Berglund P see Borges G 1660
reaction (letter). Je 1111 AP: Binge drinking during Bergstrém J see Rick C Blyler C see Cook JA
2216 ajp.psychiatryonline.org Am J Psychiatry 162:12, December 2005
ANNUAL AUTHOR INDEX
Bodnar LM, Sunder KR, Wis- RW, St. Clair D, Collier D: Butler PD, Hoptman MJ, Nier- Cassano GB see Lattanzi L
ner KL: Treatment with Association of the dysbin- enberg J, Foxe JJ, Javitt DC, Cather C see Freudenreich O
selective serotonin din gene with bipolar Lim KO: Visual white mat- CATIE Study Investigators see
reuptake inhibitors during affective disorder. Se 1636- ter integrity in schizophre- Lieberman JA; McEvoy JP;
pregnancy: deceleration of 1638 nia. No 2011-2013 Rosenheck RA; Stroup TS
weight gain because of Breier A see McGlashan TH Butler T see Epstein J Cattapan-Ludewig K See Feth
depression or drug? (case Bremner JD see Vermetten E Byrne M see Eaton WW N
conf). Je 986-991 (correc- Brenner C: Jacob A Arlow Cavalcanti MT see Amendoe-
tion, Oc 1843) (1912-2004) (image, ira MC
Boerescu D see Zimmerman psych). Se 1518 Cc Cavaleri MA see Smith MV
M Brensinger CM see Siegel SJ Cayton GA see Hirshfeld-
Bogwald K-P see Hoglend P Brent DA see Zalsman G Caesar S see Forty L Becker DR
Bohman S see Carlbring P Brewer EJ see Fehnel CR Cahard D see Laumonnier F Cea CD See Fisher CB
Bonab AA see Spencer TJ Brewster S see Forty L Calabrese JR see Bowden CL; Cerra D: Trimipramine for
Bonuccelli U see Lattanzi L Briault S see Laumonnier F Nierenberg AA; Tohen M refractory panic attacks
Bookstein FL see Barr HM Bronen RA see Amat JA Callicott JH see Tan H-Y; Win- (letter). Mr 548
Boovariwala A see Meyer JH Brotchie H see Parker G terer G Chaabouni H see Laumonnier
Borges G, Medina-Mora ME, Brown AS see Babulas V Cannon TD see Hirvonen J F
Wang PS, Lara C, Berglund Brown AS, Schaefer CA, Que- Carboon I see Creamer M Challacombe F see Stein A
P, Walters E: Treatment and senberry CP Jr, Shen L, Carlbring P, Bohman §, Brunt Chamberlain SR, Fineberg
adequacy of treatment of Susser ES: No evidence of S, Buhrman M, Westling NA, Blackwell AD, Rob-
mental disorders among relation between maternal BE, Ekselius L, Andersson bins TW, Sahakian BJ:
respondents to the Mexico exposure to herpes simplex G: Remote treatment of Motor inhibition and cog-
National Comorbidity Sur- virus type 2 and risk of panic disorder: a random- nitive flexibility in obses-
vey. Au 1371-1378 schizophrenia? De 2178- ized trial of Internet-based sive-compulsive disorder
Borjigin J see Snyder SH 2180 cognitive behavioral ther- and trichotillomania. Jy
Borras L see Mohr S Brown E see Perlis RH apy supplemented with 1282-1284
Bosch P, van den Noort M: Brown SM see Hariri 4 telephone calls. De 2119- Chang H see Adler DA
Terrorism and health ser- Brown TL see Fitzgerald PB 2125 Chapple B see McDonald C
vices utilization (letter). De Brown WH see Lee K-H Carlson GA see Margulies DM Charney DS see Monk CS;
2198 Bruder GE see Taylor BP Carnes PJ see Gold MS Zarate CA Jr
Boss V see Vaiva G Brugha TS see Torres AR Carpenter LL see Geracioti TD Chavez MR see Fenton WS
Bossie CA see Gharabawi GM Brune CW, Kim S-J, Salt J, Jr Chen C-C see Faraone SV
Bourke DL see Sandson NB Leventhal BL, Lord C, Carpenter WT Jr see Freed- Chen C-Y see Eaton WW; Far-
Bouvy PF see van Strater ACP Cook EH Jr: 5-HTTLPR man R aone SV
Bowden CL see Allen MH; genotype-specific pheno- Carpenter WT Jr: Targeting Chen G see Monk CS
Tohen M type in children and ado- schizophrenia research to Chen J see Xiao Z
Bowden CL, Calabrese JR, lescents with autism. De patient outcomes (edito- Chen J-Y see Bai YM
Ketter TA, Sachs GS, White 2148-2156 rial). Mr 353-355 Chen WJ see Faraone SV
RL, Thompson TR: Impact Brunet A see Vaiva G Carr VJ see Baker A Chen Y see McGrath PJ
of lamotrigine and lithium Brunt S see Carlbring P Carter CS see Siegle GJ Cheng J see McGrath PJ
on weight in obese and Bruun RD see Mathews CA Carter CS, Pine DS: Polishing Cheong J: The Council on
nonobese patients with Buchanan RW: Important the windows oft he mind Aging (off acts). Fe 339-340
bipolar i disorder. Jy 1199- steps in the development (editorial). My 761-763 Chou FH-C see Faraone SV
1201 : of cognitive-enhancing Carter CS: Understanding the Chou JC-Y see Tohen M
wie CR, Reichenberg A, drugs in schizophrenia glass ceiling for functional Chou P see Bai YM
Patterson TL, Heaton RK, (editorial). No 1867-1869 outcome in schizophrenia Choudhury K see Kalsi G
Harvey PD: Determinants Buchsbaum MS see Hazne- (editorial). Mr 356-358 Christopher EJ see Jiang W
of real-world functional dar MM Carter D see Misri S Chueh C-M see Faraone SV
performance in schizo- Buckholtz JW see Tan H-Y Cartwright C see Haznedar Chung EC see Jang JH
ptihornesn iwai ths ubcjoegcntist:i ocno,r rela- BuckMlaecyk iPnJ,n oMni chReAl:s ChR,a nges in CarvMeMr CS see Antoni MH CCihcucsoinde J PsEee seEep sStepienn ceJ r TJ
functional capacity, and
the psychiatric landscape Cascio C, Styner M, Smith RG, Cipriani A, Pretty H, Hawton
symptoms. Mr 418-425
(editorial). My 757-760 Poe MD, Gerig G, Hazlett K, Geddes JR: Reply to
Bracha Z see Nemets H Budman CL see Mathews CA HC, Jomier M, Bammer R, Connemann: Lithium and
Bradford J-ME see Merrill DB Budur K see Basil B Piven J: Reduced relation- suicidality revisited (Iet-
Cradley BP see Monk CS Buhrman M see Carlbring P ship to cortical white mat- ter). Mr 550
Bradley R see Westen D Buhtz F see Grabe HJ ter volume revealed by Clark DB see Tarter RE
Bradshaw JL see Silk TJ tractography-based seg- Cloninger CR see Anck-
Buitelaar J see Reyes M
Brady K, Sinha R: Reply to mentation of the corpus arsater H
Bulik C see Kaye WH; Pope
Kudler; Monterrubio, callosum in young children Colleaux L see Laumonnier F
Solowij: Chronic stress and HGjr with developmental delay. Collier D see Breen G; Demp-
adaptation (letter). Mr 553 Bullmore ET see McDonald C De 2157-2163 ster EL
Brammer M see Smith AB Burdick KE see DeRosse P Casey BJ, Durston S: From Compton WM, Conway KP,
Bramon E see Dempster EL; Burgdorf A see Dowling NM behavior to cognition to Stinson FS, Grant BF:
McDonald C Burgmair W see Engstrom EJ the brain and back: what Changes in the prevalence
Brandt P-Y see Mohr S Burke AK see Zalsman G have we learned from of major depression and
Brecher M see Harvey PD Burke- Miller JK see Cook JA functional imaging studies comorbid substance use
Brecht ML see Roll JM Burns J see Stoddard FJ of attention deficit hyper- disorders in the United
Breen G, Prata D, Osborne S, Bursztajn HJ see Gopal AA activity disorder? (edito- States between 1991-1992
Munro J, Sinclair M, Li T, Buschmann W see Nickel MK rial). Je 957-960 and 2001-2002. De 214!-
Staddon S, Dempster D, Bustillo J see Paz RD Caspi A see Ehrensaft MK; 2147
Sainz R, Arroyo B, Kerwin Butler PD see Lim KO Kim-Cohen J Conley R see Paz RD
Am | Psychiatry 162:12, December 2005 ajp.psychiatryonline.org
ANNUAL AUTHOR INDEX
Connemann BJ: Lithium and ubero P see Artaloytia JF Deeg DJH see Schoevers RA Dowling FG, Moynihan G,
suicidality revisited (let uccaro ML see Rabionet R Deeley PQ see Page LA Genet B, Lewis J: A peer-
ter). Mr 550 uijpers P see Schoevers RA Degn B see Kalsi G based assistance programs
Conners CK see Kessler R( ullen N see Walder DJ deGruy FV III: A note on the for officers with the New
Connor PD see Barr HM unningham-Williams R see partnership between psy- York City Police Depart-
Constant J see Laumonnier F Grant JE chiatry and primary care ment: report of the effects
Constantino JN, Lajonchere ‘unnington R see Silk TJ (editorial). Se 1487-1489 of Sept. 11, 2001. Ja 151-
C, Lutz M, Gray T, Abbac- urran S see Murphy DGM Dehning S see Seemiiller F 153
chi A, McKenna K, Singh urtis D see Kalsi G Dekker J see Schoevers RA Dowling NM, Megna JL, Burg-
D, Todd RD: Autistic social DelBello MP see Adler CM; dorfA , Yashaswi V: Lingual
impairment in the siblings Barzman DH lesions with orally disinte-
of children with pervasive D Delespaul P see van Os J grating risperidone (let-
developmental disorders DeLong GR see Rabionet R ter). Oc 1841-1842
Fe 294-296 Dackis CA see O'Brien CP Demirkiran S see Oral ET Doyle AE see Biederman J
Conway KP see Compton WM Dager SR see Friedman SD; Demler O see Kessler RC; Dracheva S see Haroutunian
Cook EH Jr see Brune CW Hwang J Wang PS V
Cook IA see Hunter AM Dahl AA see Mykletun A Dempster D see Breen G
Drake JE see Stoddard FJ
Cook JA, Razzano LA, Burke- Dahoun SP see Glaser B Dempster EL, Toulopoulou T,
Miller JK, Pickett-Schenk Daly E see Murphy DGM; McDonald C. Bramon E. Drake RE see Goldman HH
SA, Grey DD, Lehman AF, Page LA Walshe M, Wickham H, Drozd EM, Cromwell J, Gage
McFarlane WR, Gold PB, Daly RC see Richards M Sham PC, Murray RM, Col- B, Maier J, Greenwald LM,
Leff HS, BlylerC , Toprac Daoud SZ see Paz RD lier DA: Episodic memory Goldman HH: Patient
MG, Blankertz L, Shafer M: Daskalakis ZJ see Fitzgerald performance predicted by casemix classification for
Reply to Rosenheck: Inte PB the 2bp deletion in exon 6 Medicare psychiatric pro-
gration of mental health Dave S see Forty I of the “alpha 7-like” nico- spective payment. Ap 724-
7239
care and supported Daversa MT see Gunderson tinic receptor subunit
employment (letter). My JG gene. Oc 1832-1834 Drukker M see van Os J
940 Davidson J, Eisen MJ: Rudolf Denicoff KD see Leverich GS Druss RG: Piano sonata in A
Cooper C see Forty I Steiner (1861-1925 Denicoff KK see Zarate CA Jr major (introspections). Fe
Cooper S see Stein A image, psych). No 1897 DePaulo JR see Lin P-I; Mon- 195-197
Coppola R see Winterer G Davidson PW See Fisher CB dimore FM D'Souza J see Wagner KD
Corey-Lisle P see Olfson M Davies M see Gorman DA DePauio JR Jr: Bipolar disor-
Duberstein PR see Pinquart M
Corley RP see Young SI Davis CE see Lieberman JA; der treatment: an evi-
Cortese BM, Uhde TW: Immo McEvoy JP; Stroup TS dence-based reality check Dubovsky SL: bk rev, Hales
bilization panic (letter). Au Davis J] see Heres S (editorial). Fe 175-176 RE, Yudofsky SC, Chew
1453-1454 Davis JM see Freedman R DeRago AC see Vaillant GE RH: What Your Patients
Cotter D see Beasley ¢ Davis JM, Marder SR, Tam- DeRosse P, Funke B, Burdick Need to Know About Psy-
chiatric Medications. Ja
Cottingham EM see Klein DJ minga CA: Switch or stay? KE, Lencz T, Ekholm JM,
166
Covell NH see Essock SM editorial). De 2029-2030 Kane JM, Kucherlapati R,
Cowen P see Bhagwagar Z Davis KL see Haroutunian V Malhotra AK: Dysbindin Ducrocgq F see Vaiva G
Cox BJ see Afifi TO Davis L see McGrath PJ genotype and negative Duggal HS, Mendhekar DN:
Coyne JC, Marcus SC: Health Davis SM see Essock SM; Lie- symptoms in schizophre- Atypical antipsychotics,
disparities in care for berman JA; McEvoy JP; nia. Mr 532-534 tardive dyskinesia, and D2
depression possibly Rosenheck RA; Stroup TS Desarkar P, Thakur A, Sinha receptors (letter). Au 1449-
obscured by the clinical Dawant B see Riccardi P VK: Aripiprazole-induced 1450
significance criterion. Se De Bruin ML see Wilting I acute dystonia (letter). Je Dunn LB, Nowrangi MA,
1577-1579 de Castella A see Fitzgerald 1112-1113 Palmer BW, Jeste DV, Saks
Cozza SJ see Grieger TA PB Detke HC see Tohen M ER: Assessing decisional
Craddock N see Forty I De Jesus G see Zarate CA Jr DeVane CL see Loughhead capacity for clinical
Craske M see Roy-Byrne P de Jonge P: Reply to Thombs, AM research or treatment: a
Crawford TJ see Ettinger U Grace, Ziegelstein: Do Devos P see Vaiva G review of instruments. Au
Creamer M, Carboon I, Forbes symptom dimensions of Dietz MB see Lamberti JS 1323-1334
AB, McKenzie DP, McFar- depression following myo- DiGiacomo J see Neimark G Dunn LB, Palmer BW, Keehan
lane AC, Kelsall HL, Sim cardial infarction related DiMaria J see Roll JM M, Jeste DV, Appelbaum
MR: Psychiatric disorder differently to physical Dinzeo TJ see Docherty NM PS: Assessment of thera-
and separation from mili health indicators and car- Dixon V see Murphy K peutic misconception in
tary service: a 10-year ret diac prognosis? (letter). Jy Docherty NM, Strauss ME, older schizophrenia
rospective study. Ap 733 1296 Dinzeo TJ, St-Hilaire A: patients with a brief instru-
734 de Jonge P, Ormel J, van den rhe cognitive origins of ment. Mr 500-506
Crijns HJGM see de Jonge P Brink RHS, van Melle JP, specific types of schizo- Dunner DL see Hwang J
Crilly JF see Lamberti JS Spijkerman TA, Kuijper A, phrenic speech distur- Durst R see Raskin S
Cromwell J see Drozd EM van Veldhuisen DJ, van bances. De 2111-2118
Durston S see Casey BJ
Crow S see Lundgren JD den Berg M, Honig A, Dodd S see Berk M
Crow SJ see Pope HG Jr Crijns HJGM, Schene AH: Doi N, Usui C: Are high-risk Dvorin S see Lamberti JS
Crowe RP see Mondimore FM Symptom dimensions of haplotypes in DINBP1 and Dyck IR see Gunderson JG
Crowley TJ see Young SE depression following myo- NRG] resistance genes for
Csernansky JG see Andrews J cardial infarction and thei: schizophrenia? (letter). My
Csernansky JG, Dong H, relationship with somatic 940-941
Fagan AM, Wang L, Xiong health status and cardio- Dong H see Csernansky JG
C, Holtzman DM, Morris vascular prognosis. Ja 138 Dorahy M see van der Hart O Eastwood SL, Harrison PJ:
JC: Plasma cortisol and 144 Doshi JA see Polsky D Cellular basis of reduced
progression of dementia in De Luca V see Beitchman JH Dougherty DD see Spencer TJ cortical reelin expression
DAT subjects. De 2164 Dean L see Forty L Dougherty LR see Laptook RS in schizophrenia. Mr 540-
2169 Debbane M see Glaser B Dougherty M see Moore CM 542
2218 ajp.psychiatryonline.org Am J Psychiatry 162:12, December 2005
ANNUAL AUTHOR INDEX
Eaton JS Jr: Feldman MD: Engstrom EJ, Weber MM, Faraone SV see Biederman J; Feth N, Cattapan-Ludewig K,
Playing Sick? Untangling Burgmair W: Emil Wil- Hirshfeld-Becker DR; Sirot EJ: Electric sensa-
the Web of Munchausen helm Magnus Georg Krae- Kessler RC tions: neglected symptom
Syndrome, Munchausen pelin (1856-1926) (image, Faraone SV, Biederman J, of escitalopram discontin-
by Proxy, Malingering, and psych). Oc 1710 Spencer T, Mick E, Murray uation (letter). Ja 160
Factitious Disorder. Fe Enns MW see Lam RW K, Petty C, Adamson JJ, Filbey F see McDonald C
334-335 Epstein I see McGlashan TH Monuteaux MC: Diagnos- Findling RL see Wagner KD
Eaton WW, Byrne M, Ewald H, Epstein J, Pan H, Kocsis JH, ing adult attention deficit
Mors O, Chyen C-Y, Agerbo Yang Y, Butler T, Chusid J, hyperactivity disorder: are Fineberg NA see Chamber-
E, Mortensen PB: Associa- Hochberg H, Murrough J, late onset and subthresh- lain SR
tion of schizophrenia and Strohmayer E, Stern E, Sil- old diagnoses valid? Oc Fink M, Taylor MA: Catatonia:
autoimmune diseases: bersweig DA: Lack of ven- 1720-1729 subtype or syndrome in
linkage of Danish national tral striatal response to Faraone SV, Hwu H-G, Liu C- DSM? (editorial). No 1875-
registers. Mr 521-528 positive stimuli in M, Chen WJ, Tsuang M-M, 1876
Edelsohn GA: Hallucinations depressed versus normal Liu S-K, Shieh M-H, Fireman M see Matthews AM
in children and adoles- subjects. Oc 1784-1790 Hwang T-J, Ou-Yang W-C, First MB: Beyond clinical util-
cents: considerations in Erenberg G see Mathews CA Chen C-Y, Chen C-C, Lin J- ity: broadening the DSM-
the emergency setting Erickson CK, Wilcox RE: J, Chou FH-C, Chueh C-M, IV research appendix to
(treatment in psychiatry) Please, not “addiction” in Liu W-M, Hall M-H, Su J, include alternative diag-
My 781-785 DSM-V (letter). No 2015- Van Eerdewegh P, Tsuang nostic constructs (edito-
Eerdekens M see Reyes M 2016 MT: Genome scan of Han rial). Oc 1679-1681
Eersels J see Murphy DGM Erickson K see Lysne DH Chinese schizophrenia First MB, Zimmerman M:
families from Taiwan: con-
Egan G see Silk TJ Erlandsson K see Murphy Including laboratory tests
firmation of linkage to
Egan MF see Marenco §; Tan DGM in DSM -V diagnostic crite-
10q22.3. Oc 1760-1766
H-Y; Winterer G Ernst CL see Roffman JL ria (editorial). De 2041-
Farmer A see Forty L
Egberts TCG see Wilting I Ernst M see Monk CS 2042
Farrell M see Torres AR
Egger C see Nickel MK Ersner H see Kuroki N Fischman AJ see Spencer TJ
Farrow TFD see Lee K-H
Egleston PN see Lee K-H Essock SM, Covell NH, Davis Fartacek R see Nickel MK Fishbain DA, Gallagher RA:
Ehlers A: More evidence for SM, Stroup TS, Rosenheck Fauman MA: Defining a DSM Comments on “Prescrip-
the role of persistent disso- RA, Lieberman JA: Effec- infrastructure (editorial). tion drug dependence and
ciation in PTSD (letter). Je tiveness of switching No 1873-1874 evolving beliefs about
1112 antipsychotic medica- Fava M see McGrath PJ; Nier- chronic pain manage-
Ehrensaft MK, Moffitt TE, tions. De 2090-2095 enberg AA; Rush AJ; ment” (letter). De 2194
Caspi A: Is domestic vio- Eth S see Shalev AY Trivedi MH Fisher AD see Loughhead AM
lence followed by an Ettelt S see Grabe HJ Fava M, Rush AJ, Wisniewski Fisher CB, Cea CD, Davidson
increased risk of psychiat- Ettinger U, Picchioni M, Hall SR, Nierenberg AA, Alpert PW, Fried AL: Capacity of
ric disorders among M-H, Schulze K, Tou- JE, McGrath PJ, Thase ME, persons with mental retar-
women but not among lopoulou T, Landau S, Warden D, Biggs M, Luther dation to consent to partic-
men? a longitudinal cohort Crawford TJ, Murray RM: JF: A comparison of mir- ipate in randomized
study. My 885-892 Antisaccade performance tazapine and nortriptyline clinical trials. Oc 1813-
Ehrlichman H see Taylor BP in monozygotic twins dis- following two consecutive 1820
EEihsteens hMaJm sSee sDeea vBiedistonc hmJa n JH cTohred aMnatu dfsolr esyc hiTzwoinp hrSetnuiday:. fmaeinlteds mfeodr idceaptrieosns etdr eaotu-t - Fisher RS see Stonnington CM
Ekhator NN see Geracioti TD Mr 543-545 patients: a STAR*D report. Fitzgerald PB, Benitez J, de
Jr Everall I see Beasley C Jy 1161-1172 Castella A, Daskalakis ZJ,
EkhLoelnmc z J Tse e DeRosse P; EEvwagledn y H S sseeee ESaatlogna nWikW I Favaiznza a P,A Z:o bekl lnreevr, TR:u sAens aObrdaig-- Brtrarianoldw onomf iTszLee,qd u,eK nutlcikoaanlrt nriob lillJae:td eA r al
Ekselius L see Carlbring P nary Man. De 2202-2203 repetitive transcranial
Ekstrom RD see Golden RN F FazePli nSt,a :G rLainmni taMt:i oRnesp loyf stot udy magnetic stimulation for
El Mallakh RS, Karippot A: treatment-resistant
on violent crime and men-
Chronic depression in Faber RJ see Koran LM tal illness (letter). De 2194 depression. Ja 88-94
bipolar disorder (treatment Factor-Litvak P see Babulas V Fazel S, Grann M: The popula- Fitzmaurice GM see Reinherz
in psychiatry). Au 1337- Fagan AM see Csernansky JG tion impact of severe men- HZ
1341
Fagiolini A see Frank E; Lat- tal illness on violent crime. Flaherty LT: The Council on
Elbogen EB see Swanson JW
tanzi L Au 1397-1403 Children, Adolescents, and
Elia M see Laumonnier F Fainsinger RL, Thai V, Frank Fehnel CR, Brewer EJ: Mun- Their Families (off acts). Fe
Eliez S see Glaser B; Wood- G, Fergusson J: What's ina chausen's syndrome with 340-341
ward SH word? addiction versus 20-year follow-up (letter). Flashman LA see Wishart HA
Ell P see Murphy DGM dependence in DSM-V (let- Mr 547 Flegenheimer WV: The psy-
Ellis SP see Zalsman G ter). No 2014-2015 Fekete C see Lechan RM chotherapy of sexually
Elmquist J, Zigman J, Lutter Fairburn CG see Stein A Fenger M see Rasmussen HB impulsive patients (letter).
M: Molecular determi- Falkai P see Grabe HJ Fenton WS, Chavez MR: Medi- Ap 748
nants of energy homeosta- Fancy S see Bhagwagar Z cation-induced weight Flynn T see Araya R
sis (image, neuro) Jy 1137 Fanous AH, van den Oord E}, gain and dyslipidemia in
Emsley R, Rabinowitz J, Riley BP, Aggen SH, Neale patients with schizophre- Flynn WR: bk rev, Harris JC:
Medori R: Time course for MC, Kedler KS, O'Neill FA, nia (treatment in psychia- Intellectual Disability:
antipsychotic treatment Walsh D: Reply to Doi, try). Oc 1697-1704 Understanding Its Devel-
response in first-episode Usui: Are high-risk haplo- Fergusson J see Fainsinger RL opment, Causes, Classifi-
schizophrenia. Ap 743-745 types in DTNBP1 and Ferrando Sj see Rabkin JG cation, Evaluation, and
Treatment. Oc 1846-1847
Emslie GJ see Wagner KD NRGI resistance genes for Ferron J see Swanson JW
Endo T see Kripke DF schizophrenia? (letter). My Fertuzinhos S see Reynolds Fontaine M see Vaiva G
Engel CC see Grieger TA 940-941 GP Fontanella J see Biederman J
Am J Psychiatry 162:12, December 2005 ajp.psychiatryonline.org 2219
ANNUAL AUTHOR INDEX
Foote B, Smolin Y, Kaplan M, Frenkie!l-Fishman S see Sha- Galfalvy H see Sublette ME Goetz R see Babulas V
Legatt ME, Lipschitz D: lev AY Galina P see Salganik I Goghari VM see Khorram B
Prevalence of dissociative Freudenreich O, Cather C, Gallagher RA see Fishbain DA Gold LH: bk rev, Charles SC,
disorders in psychiatric Holt D: Stimulant misuse Ganesan V see Hunter MD Frisch PR: Adverse Events,
outpatients. Ap 623-629 in college for “pseudo- Ganzini L: Physician-assisted Stress, and Litigation: A
Forbes AB see Creamer M attention deficit disorder’ suicide (letter). Je 1109- Physician's Guide. Ja 166-
Forman RF, Woody GF during schizophrenia pro- 1110 167
McLellan T, Lynch KG: The drome (letter). No 2019 Garavan H see Murphy K Gold LH: Report of the Com-
availability of web sites Freudenreidh O see Kontos N Gardner CO see Kendler KS mittee of Tellers (off acts).
offering to sell opioid med- Freyberger HJ see Grabe HJ Gary AP: The Good Samari- Se 1662-1663
ications without prescrip- Fried AL See Fisher CB tan? (introspections). De Gold LH, Metzner JL: Psychi-
tions. Jy 1233-1238 Fried R see Biederman J 2057-2058 atric employment evalua-
Forty L, Jones L, Macgregor S, Friedman M see Zimmerman Gatz M see Kendler KS tions and the Health
Caesar S, Cooper C, Hough M Gau SS-F see Lin L Insurance Portability and
A, Dean L, Dave S, Farmer Friedman MJ: Posttraumatic Gaynes BN see Golden RN Accountability Act. No
A, McGuffin P, Brewster S, stress disorder among mili- Geddes JR see Cipriani A 1878-1882
Craddock N, Jones I: tary returnees from Gold MS, Frost-Pineda K, Car-
Familiality of postpartum Afghanistan and Iraq Genet B see Dowling FG nes PJ: Depression-related
depression in unipolar dis- treatment in psychiatry). Geracioti TD Jr, Carpenter LL, improvement with vard-
order: results of a family Ap 586-593 Owens MJ, Baker DG, enafil for erectile response
study. Se 1549-1553 Friedman SD see Hwang } Ekhator NN, Horn PS, (letter). Au 1449
Foxe JJ see Butler PD Friedman SD, Mathis CM, SKtirnakwena d JRB,, SParnicaec oLrHa, GN,e m- Gold PB see Cook JA
Frampton CMA see Mulder RT HayesC , Renshaw P, Dager eroff CB: Elevated cere- Goldapple K see Kriiger S
Frank E see Phillips ML SR: Brain pH response to brospinal fluid substance P Goldberg TE see Marenco S
Frank E, Gonzalez JM, Fagio- hyperventilation in panic concentrations in post- Golden RN, Gaynes BN,
lini A: The importance of disorder: preliminary evi- traumatic stress disorder Hamer RH, Ekstrom RD:
routine for preventing dence for altered acid-base and major depression. Ap Reply to Kripke, Tuun-
recurrence in bipolar dis- regulation. Ap 710-715 637-643 ainen, Endo: Benefits of
order (treatment in psychi Frieling H see Hillemacher T Gerig G see Cascio C; Gilmore light treatment for depres-
atry). Je 981-985 Friis S see Melle I JH sion (letter). Ja 163
corrections, Se 1648, Oc Fritsch R see Araya R Gersons BPR see Storosum JG Goldman D see Lencz T; Par-
1843 Frosch WA: bk rev, Menza M, Gharabawi GM, Bossie CA, sey RV; Zalsman G
Frank G see Fainsinger RL Marsh L, eds: Psychiatric Zhu Y: New-onset tardive Goldman HH see Drozd EM;
Frankenburg FR see Zanarini Issues in Parkinson's Dis- dyskinesia in patients with Freedman R
MC ease: A Practical Guide. Au first-episode psychosis Goldman HH, Drake RE:
Franklin C see Pliszka SR 1456-1457 receiving risperidone or Mood disorders and work-
Frederick BB see Woodward Frost-Pineda K see Gold MS haloperidol (letter). My place performance: half a
SH Frumin M see Onitsuka T 938-939 loaf (editorial). Se 1490-
Freedman R see Gabbard GO; Frye MA see Altshuler LL; Gibbons RD, Hur K, Bhaumik 149i
Lewis DA Leverich GS DK, Mann JJ: The relation- Goldney RD: On intercountry
Freedman R: bk rev, Gayford Fujita K see Tanii H ship between antidepres- adoptions (letter). Ja 162
M: The Yellow House: Van Funke B see DeRosse P sant prescription rates and Goldney RD: Suicide risk in
Gogh, Gauguin, and Nine rate of early adolescent placebo-controlled trials of
Turbulent Weekes in Arles suicide. No 1698-1904 bipolar disorder (letter). Fe
De 2202 G Gibson NA see Parker G 329
Freedman R: Nancy (¢ Gil FP see Nickel MK Goldstein BI, Herrmann N,
Andreasen, M.D., Ph.D.: Gabbard GO see Allison SE; Gilbert JR see Rabionet R Shulman KI: Comorbidity
editor emeritus perfectus Seritan AL Gillberg C see Anckarsiter H in bipolar disorder among
(editorial). Ja 3-4 Gabbard GO: bk rev, Yalom I: Gilliéron C see Mohr S the elderly: results from an
Freedman R, Carpenter WT Jr, The Schopenhauer Cure: A Gilmore JH, Lin W, Gerig G: epidemiological commu-
Davis JM, Goldman HH, Novel. Je 1118 Fetal and neonatal brain nity sample. Fe 319-321
Tamminga CA, Thomas M: Gabbard GO: When is trans- development (image, Goldstein BI, Levitt AJ: Fur-
he costs of drugs for ference work useful in neuro). De 2046 ther evidence for a devel-
schizophrenia (editorial dynamic psychotherapy? Gispen-de Wied CC see Storo- opmental subtype of
De 2031-2033 editorial). Oc 1667-1669 sum JG bipolar disorder defined by
Freedman R, Lewis DA, Mich- Gabbard GO, Bennett T: Reply Glahn DC see Pliszka SR age at onset: results from
els R, Pine DS, Schultz SK, to Flegenheimer; Koblen- Glaser B, Debbane M, Hinard the National Epidemio-
Tamminga CA: 2006 in zer: The psychotherapy of C, Morris MA, Dahoun SP, logic Survey on Alcohol
review (editorial). De 2037- sexually impulsive patients Antonarakis SE, Eliez S: and Related Conditions. Se
2040 letter). Ap 749 No evidence for an effect of 1633-1636
Freedman R, Lewis DA, Mich- Gabbard GO, Freedman R: COMT Val158Met geno- Goldstein JM see Walder DJ
els R, Pine DS, Schultz SK, Psychotherapy in the Jour- type on executive function Golinelli D see Roy-Byrne P
Tamminga C, Patterson nal: what's missing? (edito- in patients with 22q11 Gonzalez JM see Frank E
SL, McIntyre JS, Goldman rial). Fe 182-184 deletion syndrome. Mr Good KP, Whitehorn D, Rui Q,
HH, Yudofsky SC, Hales Gado MH see Andrews J 537-539 Milliken H, Kopala LC:
RE, Rapaport MH, Hales D, Gage B see Drozd EM Glick HA see Polsky D Olfactory identification
Krajeski J, Kupfer DJ, Gagliardi JP see Jiang W Glozier N see Mykletun A deficits in first-episode
Badaracco MA, Scully JH Galanter M: bk rev, Strain EC, Godart N, Berthoz S, Per- psychosis may predict
Jr: Conflict of interest, Stitzer ML, eds: The Treat- dereau F, Jeammet P: patients at risk for persis-
round 2 (editorial). Se ment of Opioid Depen- Comorbidity of anxiety tent negative and disorga-
1481-1483 dence. Se 1650 with eating disorders and nized or cognitive
Freimer NB see Mathews CA Galbraith J see Lundgren JD OCD (letter). Fe 326 symptoms. My 932-933
2220 ajp.psychiatryonline.org Am J Psychiatry 162:12, December 2005
ANNUAL AUTHOR INDEX
Gopal AA, Bursztajn HJ: tbk Grossman J: bk rev, Oldham Hamilton NG, Hamilton CA: Hauser P see Matthews AM
rev, Palermo GB, Kocsis JM, Skodol AE, Bender DS, Reply to Ganzini: Physi- Hawkins JW see Yohanan M
RN: Offender Profiling: An eds: The American Psychi- cian-assisted suicide (let- Hawkins KA see McGlashan
Introduction to the Sociop- atric Publishing Textbook ter). Je 1110 TH
sychological Analysis of of Personality Disorders. Hammerness P see Moore CM Hawton K see Cipriani A
Violent Crime. Mr 559-560 Mr 558-559 Hammond KG see Roberts LW Hayes C see Friedman SD
Gopalakrishnan R see Grunau RE see Misri S Hardan AY, Muddasani S, Hazlett EA see Haznedar MM
Thangadurai P Grunze H see Altshuler LL; Vemulapalli M, Keshavan Hazlett HC see Cascio C
Gopalakrishnan R, Jacob KS, Leverich GS; Seemiiller F MS, Minshew NJ: An MRI Haznedar MM, Buchsbaum
Kuruvilla A, Vasantharaj B, Guardino M see Terleph TA study of increased cortical MS, Hazlett EA, LiCalzi
John JK: Sildenafil in the Guellati S see Antoni MH thickness in autism. Jy EM, Cartwright C, Hol-
treatment of antipsy- Guérin P see Laumonnier F 1290-1292 lander E: Volumetric anal-
chotic-induced erectile Guerin SJ see Wishart HA Hariri A, Brown SM: Serotonin ysis and three-dimensional
dysfunction: a random- (image, neuro). Ja 12 glucose metabolic map-
Gunderson JG, Daversa MT,
ized, double-blind, pla- Grilo CM, McGlashan TH, Hariri AR, Lewis DA: Genetics ping of the striatum and
cebo-controlled, flexible- and the future of clinical thalamus in patients with
Zanarini MC, Shea MT,
dose, two-way crossover Skodol AE, Yen S, Sanislow psychiatry (editorial). Oc autism spectrum disor-
trial. Mr 494-499 1676-1678 ders. Jy 1252-1263
CA, Bender DS, Dyck IR,
Gorman DA see Amat JA Morey LC, Stout RL: Pre- Harkavy-Friedman JM: Can Heaton RK see Bowie CR
Gorman DA, Zhu H, Anderson dictors of 2-year outcome early detection of psycho- Hedeker D see Kassem L
GM, Davies M, Peterson for patients with border- sis prevent suicidal behav- Heim CM see Pace TWW
BS: Ferritin levels and their line personality disorder. ior? (editorial). My 768-770 Hemmingsen R see Rasmus-
association with regional My 822-826 Haroutunian V, Katsel P, sen HB
brain volumes in Tourette's Gunderson JG, Weinberg I, Dracheva S, Davis KL: The Hendin H: bk rev, Simon RI,
syndrome. Jy 1264-1272 Daversa MT, Kueppen- human homolog of the QKI Hales RE, eds: The Ameri-
Gorman JM: bk rev, Shapiro J: bender KD, Zanarini MC, gene affected in the severe can Psychiatric Publishing
A Year in the Life of William Shea MT, Skodol AE, Sani- dysmyelination “quaking” Textbook of Suicide Assess-
Shakespeare 1599. De mouse phenotype: down- ment and Management. Fe
slow CA, Yen S: Descriptive
2200-2202 regulated in multiple brain 331
and longitudinal observa-
Goudemand M see Vaiva G tions of the relationship of regions in schizophrenia. Hendin H, Haas AP, Malts-
Grabe HJ, Ruhrmann §, Ettelt Oc 1834-1837 berger JT, Koestner B,
borderline personality dis-
S, Buhtz F, Hochrein A, order and bipolar disorder. Harpold T see Moore CM Szanto K: Problems in psy-
Schulze-Rauschenbach §S, Jy 1173-1178 (correction, Harral EM see Pavuluri MN chotherapy with suicidal
Meyer K, Kraft S, Reck C, Oc 1843) Harrison PJ see Eastwood SL patients. Ja 67-72
Pukrop R, Freyberger HJ, Gunduz-Bruce H see Lencz T; Hartmann L; bk rev, Hibbs Henin A see Hirshfeld-Becker
Klosterkétter J, Falkai P, Robinson DG ED, Jensen PS, eds: Psy- DR
JMo: hnF amUi,l iMaaliiteyr oWf, oWbsaegsnseirve - Gur RC see Schneider F; Sie- Cchhiolsdo ciaanld TArdeoaltemsecnetnst fDoirs - HHeennnn-eHna aJs see e CZ asneaer iNneiy lManC TC
compulsive disorder in gel SJ orders: Empirically Based Henningsen P see Rief W
nonclinical and clinical Gur RE see Schneider F; Siegel Strategies for Clinical Prac- Heo M see O'Reardon JP
subjects. No 1986-1992 SJ tice, Second Edition. Jy Herbener ES see Pavuluri MN
Grace SL see Thombs BD Gurling H see Kalsi G 1302-1303 Heres S, Davis J, Maino K,
Grann M see Fazel S Gutheil T see Norris DM Harvey PD see Bowie CR; Jetzinger E, Kissling W,
Grant BF see Compton WM Gyulai L see Perlis RH Keefe RSE Leucht S: Why olanzapine
Grant JE, Potenza MN, Hol- Harvey PD, Patterson TL, Pot- beats risperidone, risperi-
lander E, Cunningham- ter LS, Zhong K, Brecher done beats quetiapine, and
Williams R, Nurminen T, H M: Improvement in social quetiapine beats olanza-
Smits G, Kallio A: Multi- competence with short- pine: an exploratory analy-
center investigation of the Ha TH see Jang JH term atypical antipsychotic sis of head-to-head
opioid antagonist Haahr U see Melle I treatment: a randomized, comparison studies of sec-
nalmefene in the treat- Haas AP see Hendin H double-blind comparison ond-generation antipsy-
ment of pathological gam- Habel U see Schneider F of quetiapine versus ris- chotics. Fe 135-194
bling. Fe 303-312 Haberstick BC see Young SE peridone for social compe- Herrera LD see Mathews CA
Grasby P see Bhagwagar Z Hadar H see Shalev AY tence, social cognition, and Herrmann N see Goldstein BI
Gray T see Constantino JN Hadzi-Pavlovic D see Parker G neuropsychological func- Hertzmann L see Stein A
Greden JF see Valenstein M Haile M see Baker A tioning. No 1918-1925 Heru AM: Family psychiatry:
Green MF see Sergi MJ Haines JL see Rabionet R Hashimoto T, Lewis DA: from research to practice.
Green RDJ see Lee K-H BDNF Val66Met polymor- Je 962-968
Hakansson C see Anckarsater
Greenberg P see Kessler RC phism and GAD67 mRNA Heruc G see Parker G
H
Greengard P see Aperia A expression in the prefron- Hettema JM, Neale MC, Myers
Halayem M see Laumonnier F
Greenhill LL see Kessler RC tal cortex of subjects with JM, Prescott CA, Kendler
Greenspan RJ see Kendler KS Hales D see Freedman R schizophrenia. Mr 534-537 KS: A population-based
Greenwald LM see Drozd EM Hales RE see Freedman R Hasin D, Samet S, Nunes E, twin study of the relation-
Grey DD see Cook JA Hall M-H see Ettinger U; Fara- Meydan J, Matseoane K, ship between neuroticism
Grieger TA, Cozza SJ, Ursano one SV Waxman R: Diagnosis of and internalizing disor-
RJ, Hoge C, Martinez PE, Halperin J see Taylor BP comorbid psychiatric dis- ders. My 857-864
Engel CC, Wain HJ: Post- Hamann J, Leucht §S, Kissling orders in substance users Hewitt JK see Young SE
traumatic stress disorder W: Reply to Preda: Do assessed with the Psychiat- Heyerdahl O see Hoglend P
and depression in battle- schizophrenia patients ric Research Interview for Heyman I see Micali N
injured soldiers. Oc 1777- want to be involved in their Substance and Mental Dis- Hibbeln JR see Sublette ME
1783 treatment? (letter). My 937 orders for DSM-IV. Ap 689- Hierholzer R: Remission rates
Grilo CM see Gunderson JG Hamer RH see Golden RN 696 for depression in STAR*D
Grinshpoon A see Levav I Hamilton CA see Hamilton Hastings RS see Parsey RV study (letter). Jy 1293
Gross R see Kolevzon A NG Hatchett AD see Zacher JL Hierholzer RW see Neylan TC
Am J Psychiatry 162:12, December 2005 ajp.psychiatryonline.org 2221
ANNUAL AUTHOR INDEX
Hietala J see Hirvonen J Holbert S see Laumonnier F Hwang J, Lyoo IK, Dager SR, Jones I see Forty L
Higgins ST: Extending contin Holland SK see Adler CM Friedman SD, Oh JS, Lee Jones L see Forty L
gency management to the Hollander E see Grant JE; JY, Kim SJ, Dunner DL, Joyce PR see Mulder RT
treatment of methamphet Haznedar MM Renshaw PF: Basal ganglia Juszczak E see Stein A
amine use disorders (edi Hollander E, Allen A: Is com- shape alterations in bipo- Jutblad S-B see Anckarsater H
torial). No 1870-1872 pulsive buying a real disor lar disorder. Fe 276-285 Juurlink DN: Reply to Benazzi:
Hill KP: Free lunch? (edito der, and is it really Hwang T-J see Faraone SV Antidepressant-induced or
rial). Ap 569-570 compulsive? (editorial). Oc Hwu H-G see Faraone SV clinician-induced suicidal-
Hill SK see Pavuluri MN 16/0-—l6/2 ity in depression? (letter).
Hillemacher T, Bleich S, Korn- Holt D see Freudenreich O Se 1644-1645
huber J, Frieling H: Hair Holtzman DM see Csernansky Juurlink DN, Mamdani MM,
oltosrsi gianse a tsriedaet meefnfetc t o(fl etltaerm JG Insel T: Beyond efficacy: the Klohep pr iAsk, Rofe dseulicmiediee rw itDhA :
Au 145] Holwerda NJ see Wilting I STAR"*D trial (editorial). Ja selective serotonin
Hiller W see Rief W Honer WG see Khorram B J— / reuptake inhibitors in the
Hilty DM: bk rev, High WM Jr, Honig A see de Jonge P Insel T, Volkow N, Li T-K: The elderly. My 813-821
Sander AM, Struchen MA, Hoogendijk WJG: bk rev, view from NIH (special Jyothi KS see Thangadurai P
Hart KA, eds: Rehabilita Swaab DF: The Human article). De 2043-2045
tion for Traumatic Brain Hypothalamus: Basic and Irani F see Siegel SJ
Injury. Oc 1845-1846 Clinical Aspects (volumes | K
Hinard C see Glaser B and II). Ap 754-755
Hines P see Olfson M Hoop J see Roberts LW J Kagan J see Stoddard FJ
Hinz R see Bhagwagar Z Hoptman MJ see Butler PD; Kallio A see Grant JE
Hirayasu Y see Kuroki N Lim KO Jacob KS see Gopalakrishnan Kaloupek DG see Woodward
R; Thangadurai P
Hirschfeld RM see Allen MH Horn PS see Geracioti TD Jr SH
Jang DP see Jang JH
Hirschfeld RMA see Kessler Horowitz MJ: bk rev, Clarkin Jang JH, Kwon JS, Jang DP, Kalsi G, McQuillin A, Degn B,
RC JE, Yeomans FE, Kernberg Moon W-J, Lee J-M, Ha TY, Lundorf MD, Bass NJ,
Hirschfeld RMA: Reply to OF: Psychotherapy for Bor Chung EC, Kim IY, Kim SI: Lawrence J, Choudhury K,
Moreira-Almeida, Pietro derline Personality: Focus \ proton MRSI study of Puri V, Nyegaard M, Curtis
bon: Does olanzapine have ing on Object Relations brain N-acetylaspartate D, Mors O, Kruse T, Kerwin
any antidepressant effect My 944-945 level after 12 weeks of cit- S, Gurling H: Identification
letter). Oc 1839 Hough A see Forty I alopram treatment in of the Slynar gene
Hirshfeld-Becker DR, Bieder Houle S see Meyer JH drug-naive patients with (AY070435) and related
man J, Henin A, Faraone Howard M see Zlotnick ( obsessive-compulsive dis- brain expressed sequences
SV, Cayton GA, Rosen- Howell HB see Smith MV order. Jy 1202-1207 as a candidate gene for
baum JF: Laboratory Howes MJ see Kessler R¢ Jansons S see Baker A susceptibility to affective
ohsbriiibpsbpskrioe tlirpiavniorlen goo dt df ii nsspb toaeurtrdhdhyeeae.nr v :ti syo oruFaaenw gli2 h t6ih5gd o-hifs2 fi7 n1 HHoowwedlmseea psnrsdeOas Dgse:iR oHn : C(sleoetetmse rpt).ua TllrksiiivSneoegd n is 1b 6yM 4i2Hnt e xt JJJJaaaevrwiavotiKmtrsO ms ekDKitC seJsPeMe e sA esdeBel eue tGrloR edaCrab Mri PtoD n;eN t L iRm daot1inin7o sd6no c 7rh-hwda1ierpt7rohls7m o 6ot btysihpporiomoclue agr ah s 1ds2ioaqscll2ioe4arl.-di ec rO c
Hirvonen J, van Erp TGM, Hsiao JK see Lieberman JA; Jefferson JW: bk rev, Stein DJ, Kampman K see O'Brien CP
Huttunen J, Aalto S, McEvoy JP; Rosenheck RA; Kupfer DJ, Schatzberg AF, Kanas N: Group therapy with
Nagren K, Huttunen M, Stroup TS eds: The American Psychi- schizophrenia patients
Lénngqvist J, Kaprio J, Can- Hu X see Parsey RV; Zalsman atric Publishing Textbook letter). My 937-938
non TD, Hietala J: Brain G of Mood Disorders. Oc Kanayama G, Barry S, Hud-
dopamine D1 receptors it Huang Y-y see Parsey RV; 1844 son JI, Pope HG Jr: Body
twins discordant for Zalsman G Jenkins R see Torres AR image and attitudes toward
schizophrenia. Oc 1747 Hudson JI see Kanayama G; Jeste DV see Dunn LB male roles in anabolic-
1753 Pope HG Jr Jetzinger E see Heres S androgenic steroid users.
Hjern A see Lindblad f Huggins JE see Barr HM Jiang W: Reply to Penland: Ap 697-703
Hochberg H see Epstein J Huguelet P see Mohr S Lipids, hormones, and gas- Kane JM see DeRosse P; Lencz
Hochrein A see Grabe HJ Hunt JP see Scheeringa MS tric bypass (letter). Je 1113- T; Robinson DG
Hodo DW: bk rev, Dadock BJ, Hunter AM, Leuchter AF, Mor- 1114 Kane JM: Tardive dyskinesia
Kaplan HI: Kaplan and gan ML, Cook IA: Changes Jiang W, Gagliardi JP, Raj YP, circa 2006 (editorial). Au
Sadock's Comprehensive in brain function (quanti Silvertooth EJ, Christo- 1316-1318
Textbook of Psychiatry tative EEG cordance) dur pher EJ, Krishnan KRR: Kanes SJ see Siegel SJ
Eighth Edition. Au 1458 ing placebo lead-in and Acute psychotic disorde1 Kang JW see Keefe RSE
(correction, De 2199 treatment outcomes in after gastric bypass sur- Kaplan M see Foote B
Hoffman RE see McGlashan clinical trials for major gery: differential diagnosis Kaplan P see Nickel MK
TH depression. Au 1426-1432 and treatment (case conf). Kaprio J see Hirvonen J
HogeC see Grieger TA Hunter MD see Lee K-H Ja 15-19 Kapur S see Remington G
Hoglend P, Amlo S, Marble A, Jin R see Kessler RC; Shear K Karippot A see El Mallakh RS
Hunter MD, Ganesan V,
Begwald K-P, Sorbye @, Joa I see Melle I Kassem L, Lopez V, Hedeker
Wilkinson ID, Spence SA:
Sjaastad MC, Heyerdahl O: Johannesen JO see Melle I D, Steele J, Zandi P, NIMH
Impact of modafinil on
Analysis of the patient Johansen L see Streltzer J Genetics Initiative Bipolar
prefrontal executive func-
therapist relationship in John JK see Gopalakrishnan R Disorder Consortium,
tion in schizophrenia. De
dynamic psychotherapy 2184-2186 John U see Grabe HJ McMahon FJ: Familiality of
an experimental study of Johnson B see Streltzer J polarity at illness onset in
transference interpreta- Hur K see Gibbons RD Johnston D see Rosenberg PB bipolar affective disorder.
tions. Oc 1739-1746 Hurford MO see Neimark G Jolesz FA see Kuroki N Oc 1754-1759
Hokfelt T, Kuteeva E: Sub- Hutto B see Perea E Jomier M see Cascio C Katabira E see Nakimulli-
stance P: a neuropeptide Huttunen J see Hirvonen J Jones DW see Winterer G Mpungu E
(image, neuro). Ap 578 Huttunen M see Hirvonen J Jones HM see Uher R Katsel P see Haroutunian V
2222 ajp.psychiatryonline.org Am J Psychiatry 162:12, December 2005
ANNUAL AUTHOR INDEX
Kaufman J see Murphy K Kessler RC, Adler L, Barkley R, Kirisci L see Tarter RE Kraft S see Grabe HJ
Kaye WH, Bulik C, Thornton Biederman J, Conners CK, Kirmayer L see Miresco MJ; Krajeski J see Freedman R
L, Plotnicov K, Price Foun- Demler O, Faraone SV, Sharpe M Kripke DF, Tuunainen A, Endo
dation Collaborative Greenhill LL, Howes MJ, Kissane DW, McKenzie M, T: Benefits of light treat-
Investigators: Reply to Secnik K, Spencer T, Ustun Bloch S, Moskowitz C, ment for depression (let-
Godart, Berthoz, Per- TB, Walters EE, Zaslavsky McKenzie DP, O'Neill I: ter). Ja 162-163
dereau, Jeammet; Micali AM: The prevalence and Family focused grief ther- Krishnan GP see Skosnik PD
Heyman; Sédersten, Bergh: correlates of adult ADHD apy: a randomized con- Krishnan KRR see Jiang W
Comorbidity of anxiety in the United States: results trolled trial in palliative Kroenke K see Sharpe M
with eating disorders and from the National Comor- care and bereavement. Jy Krokstad S see Mykletun A
OCD (letter). Fe 327-329 bidity Survey Replication. 1208-1218 Kriiger S, Alda M, Young LT,
Kazi A see Antoni MH Ap 716-723 Kissling W see Hamann J; Goldapple K, Parikh S,
Keck PE Jr see Altshuler LL; Kessler RC, Akiskal HS, Ames Heres S Mayberg HS: Risk and
Leverich GS M, Birnbaum H, Green- Kitchen CMR see Altshuler LL resilience markers in bipo-
Keefe RSE see Lieberman JA; berg P, Hirschfeld RMA, Jin Kleber HD see Miller JM lar disorder: brain
McEvoy JP; Rosenheck RA; R, Merikangas KR, Simon Klein DJ, Cottingham EM, responses to emotional
Stroup TS GE, Wang PS: Prevalence Sorter M, Barton BA, Mor- challenge in bipolar
Keefe RSE, Poe M, Walker TM, and effects of mood disor- riscn JA: A randomized, patients and their healthy
Kang JW, Harvey PD: The ders on work performance double-blind. placebo- siblings. Fe 257-264
Schizophrenia Cognition in a nationally representa- controlled trial of met- Kruse T see Kalsi G
Rating Scale: an interview- tive sample of U.S. work- formin treatment of weight Kruszewski SP: Euphorigenic
based assessment and its ers. Se 1561-1568 gain associated with initia- and abusive properties of
relationship to cognition, Ketter TA see Bowden CL; tion of atypical antipsy- modafinil (letter). Mr 549
real-world functioning, Nierenberg AA; Perlis RH chotic therapy in children Kucherlapati R see DeRosse P
and functional capacity. Kettler C see Nickel MK and adolescents. De 2072- Kudler H: Chronic stress and
Mr 426-432 Keyes BB see Xiao Z 2079 adaptation (letter). Mr
Keehan M see Dunn LB Khadivi A see Robinson DG Klein DN see Laptook RS 552-553
Keith SJ: Are we still talking to Khantzian EJ: bk rev, Petry Klein DN, Shankman SA, Rose Kueppenbender KD see Gun-
our patients with schizo- NM: Pathological Gam- S: Ten-year prospective fol- derson JG
phrenia? (editorial). Mr bling: Etiology, Comorbid- low-up study of the natu- Kuhlenshmidt HA see Skosnik
362-364 ity, and Treatment. My ralistic course of dysthymic PD
945-946 disorder and double
Kellogg S see Roll JM Kuijper A see de Jonge P
Khorram B, Lang DJ, Kopala depression. My 872-880
Kelly KI see Sule A Kulkarni J see Fitzgerald PB
LC, Vandorpe RA, Rui Q, Klein RG see Terleph TA
Kelsall HL see Creamer M Kupfer DJ see Freedman R;
Goghari VM, Smith GN, Kleinman A see Patel V
Kendler KS see Fanous AH; Honer WG: Reduced tha- Kline NA: Revisiting once Rush AJ
Hettema JM lamic volume in patients upon a time (introspec- Kupfer DJ: The Council on
Kendler KS: Reflections on the with chronic schizophre- tions). Jy 1147-1148 Research (off acts). Fe 350-
relationship between psy- nia after switching from Klosterk6tter J see Grabe HJ 351
chiatric genetics and psy- typical antipsychotic med- Knobler HY see Kolevzon A Kupka R see Altshuler LL;
chiatric nosology. Jy 1138- ications to olanzapine. No Koblenzer J: The psychother- Leverich GS
1146 2005-2007 apy of sexually impulsive Kuroki N see Onitsuka T
Kendler KS: Reply to Khorram B, Lang DJ, Kopala patients (letter). Ap 748- Kuroki N, Shenton ME, Saiis-
Rietschel, Propping, LC, Vandorpe RA, Rui Q, 749 bury DF, Hirayasu Y, Onit-
Néthen: The impact of Goghari VM, Smith GN, Koch K see Schneider F suka T, Ersner H,
genetics on psychiatric Honer WG: Reduced tha- Kocsis JH see Epstein J Yurgelun-Todd D, Kikinis
nosology (letter). De 2198 lamic volume in patients Koestner B see Hendin H R, Jolesz FA, McCarley RW:
Kendler KS, Gardner CO, with chronic schizophre- Kohler CG see Siegel SJ Middle and inferior tem-
Prescott CA: Toward a nia after switching from Kohn R see Vicente B poral gyrus gray matter
comprehensive develop- typical antipsychotic med- Kolevzon A, Weiser M, Gross volume in first-episode
mental model for major ications to olanzapine. No R, Lubin G, Knobler HY, schizophrenia: an MRI
depression in men. Ja 115- 2005-2007 (correction, De Schmeidler J, Silverman study. De 2103-2110
124 2199) JM, Reichenberg A: Effects Kuruvilla A see Gopalakrish-
Kendler KS, Gatz M, Gardner Khurshid KA: A tale of two cit- of season of birth on nan R; Thangadurai P
CO, Pedersen NL: A Swed- ies (introspections). Au autism spectrum disor- Kuteeva E see Hokfelt T
ish national twin study of 1335-1336 ders: fact or fiction? Jy Kutter CJ see Woodward SH
lifetime major depression. Kikinis R see Kuroki N 1288-1290 Kwon JS see Jang JH
Ja 109-114 Kim IY see Jang JH Kontos N, Freudenreich O,
Kendler KS, Greenspan RJ: Kim M see Swanson JW Querques J: Using a medi-
The nature of genetic influ- Kim SI see Jang JH cal model with psychotic L
ences on behavior: lessons Kim S-J see Brune CW patients (letter). Se 1646-
from “simpler” organisms. Kim SJ see Hwang J 1647 Labelle A see Remington G
Oc 1683-1694 Kim-Cohen J, Caspi A, Rutter Kopala LC see Good KP; Khor- Laffargue P see Vaiva G
Kendrick K see Misri S M, Tomas MP, Moffitt TE: ram B LaGrave K see Murphy K
Kennedy JL see Beitchman JH The caregiving environ- Kopp A see Juurlink DN Lahti A see Artaloytia JF
Kenny ET see Miller JM ments provided to children Koran LM, Faber RJ, Abou- Lajonchere C see Constantino
Kerwin R see Beasley C; Breen by depressed mothers with jaoude E, Large MD, Serpe JN
G; Murphy DGM or without an antisocial RT: Estimated prevalence Lalonde JK see Pope HG Jr
Kerwin S see Kalsi G history. Je 1009-1018 of compulsive buying Lam RW, Levitt AJ, Levitan
Keshavan MS see Hardan AY; Kimble MO see Woodward SH behavior in the United RD, Enns MW, Morehouse
Rao A King N see Beitchman JH States. Oc 1806-1812 R, Michalak EE, Tam EM:
Kessler R see Riccardi P King-Hele SA see Webb RT Kornhuber J see Hillemacher The Can-SAD study: a ran-
Kessler RC see Shear K; Wang Kingdon D see Turkington D T domized controlled trial of
PS Kinkead B see Geracioti TD Jr Kowatch RA see Wagner KD the effectiveness of light
Am J Psychiatry 162:12, December 2005 ajp.psychiatryonline.org 2223
ANNUAL AUTHOR INDEX
therapy and fluoxetine in Lee K-H, Brown WH, Egleston Levine A see Adler CM Lin P-I, McInnis MG, Potash
patients with winter sea- PN, Green RDJ, Farrow Levine J see Amital D JB, Willour V, MacKinnon
sonal affective disorder. My TFD, Hunter MD, Parks Levine J, Belmaker RH: DF, DePaulo JR, Zandi PP:
805-812 RW, Wilkinson ID, Spence Osteoporosis and schizo- Clinical correlates and
Lamberti JS, Olson D, Crilly SA, Woodruff PWR: A func phrenia (letter). Mr 549- familial aggregation of age
FE,O livT,a Wirlleiamss GC, tional magnetic resonance 550 at onset in bipolar disor-
Tu X, Tang W, Wiener K, imaging study of social Levinson DF see Mondimore der. Fe 240-246
Dvorin S, Dietz MB: Preva cognition in schizophrenia FM Lin W see Gilmore JH
lence of the metabolic syn during an acute episode Levitan RD see Lam RW Lindberg L see Lindblad F
drome among patients and after recovery. No Lindblad F, Lindberg L, Hjern
Levitt AJ see Goldstein BI;
receiving clozapine. Jy 1926-1933 A: Improved survival in
Lam RW
127 —12 76 Lee M-B see Lin I adolescent patients with
Levy NB: bk rev, Roose SP,
Landau S see Ettinger U Leff HS see Cook JA anorexia nervosa: a com-
Sackeim HA, eds: Late-Life
Lane B see Woodward SH Legatt ME see Foote B Depression. Fe 332 parison of two Swedish
LLaanngg DJ:J Tsheee KChoounrcrila mo n B Medi LLeehhmmaann RABF sseeee CWoaogkn eJrA KD Lewin TJ see Baker A ninaptaitoineanlt s.c ohAour ts1 43o3f -f1e4m3a5l e
cal Education and Lifelong Leibenluft E see Monk CS Lewine R: bk rev, Kingdon DG, Lindborg S see McGlashan TH
Learning (off acts). Fe 343 Lencz T see DeRosse P lurkington D: Cognitive Linden D see Wagner KD
344 Lencz T, Robinson DG, Xu K, Therapy of Schizophrenia. Lindley SE see Neylan TC
Lapitsky L see Adler DA Ekholm J, Sevy S, Gunduz- Au 1455 Lindner S see Vermetten E
LaptsDtooaoubkigl hiteRyrS ,t yof K ldeLeiRpn:r eDsTNes,ni -vyee arpe t hBKoratunrceae JAHMK,,: WGDooRelDrd2nm earnp r MomGD,o, t Mearl - LewiSHsia briiDlrlAie sAEeR e; FHraesehdimmaont o R;T ; LLLiiiopntsstciz heinMt z DseHDe sPseeleei sFzSoktaoo treSo Rs Bu m JG
sonality disorder in region variation as a pre- Lewis DA, Michels R, Pine DS, Liskow B: bk rev, McLaren KD,
depressed outpatients. My dictor of sustained Schultz SK, Tamminga CA, Martin CD, Hebig P: Psy-
865-871 response to antipsychotic Freedman R: Conflict of chiatry Clerkship: 150 Big-
Lara C see Borges G mscehdiizcoapthiroenn iian fpiartsite-ntesp.i soMdre 5in7t3e rest (editorial). Ap 571- gAevsoti d MiTsthaekme.s Naon d2 0H2o3w-2 0t2o 4
Large MD see Koran LM
5929-531 Lewis G see Torres AR L'Italien GJ see Olfson M
Larsen TK see Melle I
Lenoci M see Neylan T(¢ Lewis J see Dowling FG Liu C-M see Faraone SV
Larson T see Anckarsater H
Leonard S, Adams CE: Smok- Li R see Riccardi P Liu S-K see Faraone SV
Lattanzi L, Mungai F, Romano
ing cessation and schizo- Li T see Breen G Liu W-M see Faraone SV
A, Bonuccelli U, Cassano
GB, Fagiolini A: Subcuta phrenia (image, neuro). No Li T-K see O'Brien CP Livni E see Spencer TJ
neous apomorphine for 1877 LiCalzi EM see Haznedar MM Loew TH see Nickel MK
neuroleptic malignant syn Lerner D see Adler DA Liebenluft E: Flying almost Loewenstein RJ see Vermetten
drome (letter). Au 1450 Lerner V, Witztum E: Victor blind (editorial). Jy 1129 E
1451 Kandinsky, M.D., 1849 1131 Lénngqvist J see Hirvonen J
Laumonnier F, Roger S, 1889 (image, psych). Fe 209 Lieber CE see Pardes H Lopez V see Kassem L
Leslie DL see Rosenheck RA Lord C see Brune CW
Guérin P, Molinari F, Lieberman JA see Essock SM;
Lesser ML see Robinson DG Lorell BS see Robinson DG
M'Rad R, Cahard D, Belh- McEvoy JP; Merrill DB;
Leucht S see Hamann J; Heres Loughhead AM, Fisher AD,
aAdMj, A,E liHaa lMa,y eRmo maM,n oP erVs,i co Ss SPternonu pD LT;S Rosenheck RA; Newport DJ, Ritchie JC,
Leuchter AF see Hunter AM Owens MJ, DeVane CL,
Holbert S, Andres C, Lieberman JA, Stroup TS,
Chaabouni H, Colleaux L, Levav I see Vicente B McEvoy JP, Swartz MS, Stowe ZN: Antidepressants
Constant J, Le Guennec J- Levav I: Reply to Bosch, van Rosenheck RA, Perkins in amniotic fluid: another
Y, Briault S: Association of den Noort: Terrorism and DO, Keefe RSE, Davis SM, route of fetal exposure. Ja
a functional deficit of the health services utilization Davis CE, Hsiao J, Severe J, 145-147
BKCa channel, a synaptic letter). De 2198-2199 Lebowitz BD, The CATIE Lovel M see Stein A
regulator of neuronal excit Levav I, Novikov I, Grinsh- Investigators: Reply to Lowe TL see Mathews CA
ability, with autism and poon A, Rosenblum J, Teich; Basil, Mathews, Ade- Lu FG: The Council on Minor-
mental retardation. Se Ponizovsky A: Health ser tunji B, Budur K: The ity Mental Health and
1622-1629 vices utilization in Jerusa CATIE Study (letter). Mr Health Disparities (off
lem under terrorism. Au acts). Fe 345-346
Lavori PW see Rush AJ
1355-1361 Lubin G see Kolevzon A
Lawrence J see Kalsi G Lim KO see Butler PD
Leventhal BL see Brune CW Lublin H see Rasmussen HB
Layde JB, Roberts LW: bk rev, Lim KO, Ardekani BA, Nieren-
Leverich G see Altshuler LL Lucero L see Roll JM
Gazzaniga MS: The Ethical berg J, Butler PD, Javitt
Leverich GS: Reply to Mattes Luchins D: bk rev, Petryna A,
Brain. Ap 751 DC, Hoptman MJ: Voxel-
Less mood switching with Lakoff A, Kleinman A, eds:
Lazarus J: The Council on wise correlational analyses
venlafaxine? (letter). Se Global Pharmaceuticals:
Advocacy and Public Policy of white matter integrity in
1642 Ethics, Markets, Practices.
(off acts). Fe 337-339 multiple cognitive
Leverich GS, Altshuler LL, Jy 1301
Le Guennec J-Y see Laumon- domains in schizophrenia
Frye MA, Suppes T, McE]- Lucia LC see Onitsuka T
nier F No 2008-2010
roy SL, Keck PE Jr, Kupka Luckenbaugh DA see Zarate
Lebowitz B see Lieberman JA; RW, Denicoff KD, Nolen Lin C-C see Bai YM CAJr
Nierenberg AA; Rush AJ; WA, Grunze H, Martinez Lin C-Y see Bai YM Lundgren JD see O'Reardon
Trivedi MH MI, Post RM: Risk of switch Lin DY see Tohen M JP
Lechan RM, Fekete C: Central in mood polarity to hypo- Lin H see Rosenheck RA Lundgren JD, Allison KC,
mechanisms for thyroid mania or mania in patients Lin J-J see Faraone SV Crow S, O'Reardon JP, Berg
hormone regulation with bipolar depression Lin L, Gau SS-F, Lee M-B: KC, Galbraith J, Martino
(image, neuro). Se 1492 during acute and continu- Binge eating associated NS, Stunkard AJ: Preva-
Lechner SC see Antoni MH ation trials of venlafaxine, with internal carotid artery lence of the night eating
Lee J see Stein A sertraline, and bupropion aneurysm (letter). Au syndrome in a psychiatric
Lee J-M see Jang JH as adjuncts to mood stabi- 1452-1453 (correction, No population. Ja 156-158
Lee JY see Hwang J lizers. Fe 232-239 2020) Lundorf MD see Kalsi G
2224 ajp.psychiatryonline.org Am J Psychiatry 162:12, December 2005